Zacks' Voice of the People highlights opportunities with Starbucks, Realty Income, Keryx Biopharma, Bon-Ton Stores and Orexigen Therapeutics - Press Releases

By
A A A
Share |

For Immediate Release

Chicago, IL - 04/12/2012 - Zacks highlights commentary from People and Picks Trader " RobMarketsBlind " .

For more Voice of the People, visit http://at.zacks.com/?id=5851

Featured Post

Latest RTMB Trades

"Rob The Markets Blind" (RTMB) made a number of trades yesterday. As always stated, our methodology works best on big market down days. We have been doing trades in our methodology for over a year now and each and every trade has been a winner.

We have announced each trade on this site, usually on the very day the trade was made. We also stated that we are no longer going to provide each and every pick on here but will offer some trades from time to time.

Yesterday was an excellent day for writing puts (our main method of trading) as premiums on strong dividend stocks were up. We also are buying momentum stocks and adding to positions as we did with Starbucks ( SBUX ).

We also are adding to our share positions as we did with Realty Income Corp. ( O ) a stock that pays monthly dividends, one where the share price has increased, one with 57 straight quarterly dividend increases, one which has paid a dividend monthly for 498 straight months. The rate is 4.7% currently; our YOC is much higher.

The most recent picks by «RobMarketsBlind» are:
A buy rating on Keryx Biopharma ( KERX ),
a buy rating on Bon-Ton Stores ( BONT ) and
a buy rating on Orexigen Therapeutics ( OREX ).

About the Zacks Community

In 2008, Zacks Investment Research launched PeopleAndPicks.com, a stock-picking website where members of the Zacks community can test their strategies and share ideas with other members. Each user is scored on the accuracy of his or her picks, and top users are rewarded with free products from Zacks. Registration is free. To learn more about People And Picks, visit http://at.zacks.com/?id=5957

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3:1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit From the Pros by going to http://at.zacks.com/?id=5958 .

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact: Brent Billock
People & Picks Manager
Company: Zacks.com
Phone: 312-265-9307
Email: pandp@zacks.com
Visit: www.Zacks.com


 
BON-TON STORES ( BONT ): Free Stock Analysis Report
 
KERYX BIOPHARMA ( KERX ): Free Stock Analysis Report
 
REALTY INCOME ( O ): Free Stock Analysis Report
 
OREXIGEN THERAP ( OREX ): Free Stock Analysis Report
 
STARBUCKS CORP ( SBUX ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks

Referenced Stocks: BONT , KERX , O , OREX , SBUX

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

72,157,294
  • $61.36 ▼ 2.65%
56,535,455
  • $34.92 ▼ 3.78%
49,608,479
  • $4.42 ▼ 3.07%
49,328,445
  • $25.91 ▼ 3.18%
48,932,529
  • $16.37 ▲ 0.49%
38,182,422
  • $3.17 ▼ 1.55%
33,297,581
  • $73.86 ▲ 1.37%
32,790,375
  • $47.43 ▼ 1.02%
As of 4/23/2014, 04:07 PM